...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Synthesis of novel 4-thiazolidione derivatives as antibacterial agents against drug-resistant Staphylococcus epidermidis
【24h】

Synthesis of novel 4-thiazolidione derivatives as antibacterial agents against drug-resistant Staphylococcus epidermidis

机译:新型4-噻唑烷酮衍生物作为抗耐药性表皮葡萄球菌的抗菌剂的合成

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel substituted 4-thiazolidione derivatives were designed, synthesized, and evaluated in vitro for their antibacterial activities, in comparison with methicillin and ampicillin. Compounds (7d, 7h-k) exhibit good potency in inhibiting the growth of Staphylococcus epidermidis (MIC: 1.57-3.13 muM). Further antibacterial effects of compounds (7d, 7h-k) were investigated using clinical isolates (methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus), in comparison with methicillin and levofloxacin. Compound 7k showed the most potent antibacterial activities among the synthesized compounds.
机译:与甲氧西林和氨苄青霉素相比,设计,合成了一系列新颖的取代的4-噻唑烷酮衍生物,并在体外评估了它们的抗菌活性。化合物(7d,7h-k)在抑制表皮葡萄球菌(MIC:1.57-3.13μM)的生长中表现出良好的效力。与甲氧西林和左氧氟沙星相比,使用临床分离株(耐甲氧西林的表皮葡萄球菌和耐甲氧西林的金黄色葡萄球菌)研究了化合物(7d,7h-k)的进一步抗菌作用。在合成的化合物中,化合物7k显示出最有效的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号